Racial-Ethnic Disparities in Ketamine and Esketamine Therapy for Major Depressive Disorder
Significant racial-ethnic disparities exist in the utilization of ketamine and esketamine therapies for major depressive disorder, particularly affecting Black patients. Future research should investigate the underlying causes of these disparities and develop strategies to ensure equitable access to ketamine and esketamine for all patients with major depressive disorder.
Authors
- David C. Kaelber (ORCID: https://orcid.org/0000-0001-7855-9515)
- Keming Gao (ORCID: https://orcid.org/0000-0003-1130-2461)
- Rachel Branning (ORCID: https://orcid.org/0000-0003-4948-6614)
- Austin Lee
- Michael Liu
Institutions
- University Hospitals of Cleveland (US)
Publication Details
- Journal
- Psychiatric Services
- Published
- 2025-06-25
- DOI
- https://doi.org/10.1176/appi.ps.20240559
- Citations
- 1
- Primary Topic
- Treatment of Major Depression
- Type
- article
- Field-Weighted Citation Impact
- 1.39